An object of the present invention is to provide a glass for pharmaceutical containers, which is resistant to delamination and has excellent processibility. The glass for pharmaceutical containers of the present invention comprises, in mol% on an oxide basis, 69 to 81% of Si02, 4 to 12% of A120 3, 0 to 5% of B20 3, 5 to 20% of Li20 + Na20 + K20 , 0.1 to 12% of Li20 , and 0 to 10% of MgO + CaO + SrO + BaO. The glass has a hydrolytic resistance of Class 1 in a test in accordance with the European pharmacopoeia.
